Light Mode
$14.99 ↑ +0.00 (+0.00%) Trading Up from the previous close of $14.99, $0.04 below the day’s high of $15.03
+3.07 (+26.04%) / 6M
Momentum, market sentiment, and recent alerts
FSNUY reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +1.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.